TED Ted Baker Plc

    RNS Number : 0414A
  Tepnel Life Sciences PLC
  28 July 2008
   

    


    Tepnel Life Sciences plc ('Tepnel' or 'the Company')

    Tepnel to announce interim results for 2008


    Manchester, UK - 28th July 2008 Tepnel Life Sciences PLC (AIM: TED), the UK-based international Molecular Diagnostics and Research
Products & Services group, will release its interim results for the 6 months ended 30 June 2008 on Thursday, July 31, 2008 at approximately
7:00am UK time. 





    -End-






    For Further Information:

    Tepnel Life Sciences plc
    Ben Matzilevich, CEO; Mick Slater, Group Finance Director; Carol Smith, Group Marketing Communications Manager
    0161 946 2200

    Capital MS&L
    Mary Clark or Joey Whineray
    Tel: +44 20 7307 5330

    Seymour Pierce Limited
    Mark Percy
    Tel: +44 20 7107 8000


    Notes to Editors

    About Tepnel Life Sciences plc
    Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services group with two main divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with 215
employees.  TLS provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research.  The company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets. 
TLS focuses on these niche opportunities with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these defined market segments.



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
NORKGGZNDRLGRZM

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024